Franco Bergesio

455 total citations
26 papers, 237 citations indexed

About

Franco Bergesio is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Franco Bergesio has authored 26 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Franco Bergesio's work include Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Parathyroid Disorders and Treatments (5 papers) and Peptidase Inhibition and Analysis (4 papers). Franco Bergesio is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers), Parathyroid Disorders and Treatments (5 papers) and Peptidase Inhibition and Analysis (4 papers). Franco Bergesio collaborates with scholars based in Italy, United States and Netherlands. Franco Bergesio's co-authors include Francesco Cappelli, Federico Perfetto, Maria Cristina Porciani, Paola Attanà, Alberto Moggi Pignone, Francesco Salinaro, Stefano Perlini, Maurizio Salvadori, Martina Smorti and A Miliani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nephrology Dialysis Transplantation and Haematologica.

In The Last Decade

Franco Bergesio

22 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franco Bergesio Italy 9 150 104 87 28 26 26 237
Sara Rosengren Sweden 7 290 1.9× 156 1.5× 118 1.4× 63 2.3× 62 2.4× 12 379
Lisa Mendelson United States 9 199 1.3× 65 0.6× 14 0.2× 12 0.4× 42 1.6× 23 224
Kai Immonen Finland 8 70 0.5× 34 0.3× 19 0.2× 29 1.0× 10 0.4× 9 147
Sabahat Alışır Türkiye 9 84 0.6× 116 1.1× 31 0.4× 67 2.4× 5 0.2× 17 288
Yousuf Razvi United Kingdom 10 218 1.5× 106 1.0× 47 0.5× 30 1.1× 47 1.8× 35 288
R. Baatard France 9 67 0.4× 111 1.1× 11 0.1× 47 1.7× 10 0.4× 20 345
Mattia Zampieri Italy 11 166 1.1× 65 0.6× 217 2.5× 27 1.0× 44 1.7× 51 353
Lenka Bauerová Czechia 7 66 0.4× 41 0.4× 8 0.1× 28 1.0× 25 1.0× 11 141
Feng Ding China 8 43 0.3× 29 0.3× 10 0.1× 10 0.4× 15 0.6× 18 218
Alessia Argirò Italy 11 154 1.0× 41 0.4× 230 2.6× 10 0.4× 33 1.3× 53 344

Countries citing papers authored by Franco Bergesio

Since Specialization
Citations

This map shows the geographic impact of Franco Bergesio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Bergesio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Bergesio more than expected).

Fields of papers citing papers by Franco Bergesio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Bergesio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Bergesio. The network helps show where Franco Bergesio may publish in the future.

Co-authorship network of co-authors of Franco Bergesio

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Bergesio. A scholar is included among the top collaborators of Franco Bergesio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Bergesio. Franco Bergesio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bergesio, Franco, et al.. (2021). GCND per il pianeta. Un forte invito ad agire per tutti: medici, infermieri e pazienti. SHILAP Revista de lepidopterología. 33. 1–2. 1 indexed citations
3.
Perfetto, Federico, Francesco Cappelli, Silvia Farsetti, et al.. (2019). Amiloidosi da transtiretina (ATTR): l’altra faccia della medaglia. SHILAP Revista de lepidopterología. 31(1). 12–21.
4.
Farsetti, Silvia, et al.. (2017). The Diagnostic Path of Amyloidosis. When to Think of it and how to Find it. 29(3). 157–162. 1 indexed citations
5.
Farsetti, Silvia, et al.. (2017). Amiloidosi, il Percorso Diagnostico. Quando Pensarci e Come Trovarla. SHILAP Revista de lepidopterología. 29(3). 157–162. 1 indexed citations
6.
Terreni, Alessandro, et al.. (2016). [Free light chains reduction on acute kidney injury in multiple myeloma: critical role of high cut-off membranes].. PubMed. 31(6).
7.
Cappelli, Francesco, Samuele Baldasseroni, Franco Bergesio, et al.. (2016). Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system. Internal and Emergency Medicine. 12(1). 23–30. 2 indexed citations
8.
Perfetto, Federico, Franco Bergesio, Elisa Grifoni, et al.. (2016). Different NT-proBNP circulating levels for different types of cardiac amyloidosis. Journal of Cardiovascular Medicine. 17(11). 810–817. 25 indexed citations
9.
Smorti, Martina, et al.. (2013). Depression and cardiac symptoms among AL amyloidosis patients: the mediating role of coping strategies. Psychology Health & Medicine. 19(3). 263–272. 10 indexed citations
10.
Smorti, Martina, Francesco Cappelli, Franco Bergesio, & Federico Perfetto. (2012). Anxiety and depression among AL amyloidosis patients: the role of cardiac symptoms. Amyloid. 19(3). 123–128. 11 indexed citations
11.
Cappelli, Francesco, Maria Cristina Porciani, Franco Bergesio, et al.. (2011). Right ventricular function in AL amyloidosis: characteristics and prognostic implication. European Heart Journal - Cardiovascular Imaging. 13(5). 416–422. 87 indexed citations
12.
Cappelli, Francesco, et al.. (2010). Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. Clinical Physiology and Functional Imaging. 31(2). no–no. 17 indexed citations
13.
Tarquini, Roberto, Federico Perfetto, Franco Bergesio, et al.. (2007). A new ATTR Phe64Ile mutation with late-onset multiorgan involvement. Amyloid. 14(4). 289–292. 1 indexed citations
14.
Frascà, Giovanni M., Andrea Onetti Muda, Francesca Mari, et al.. (2004). Thin glomerular basement membrane disease: clinical significance of a morphological diagnosis--a collaborative study of the Italian Renal Immunopathology Group. Nephrology Dialysis Transplantation. 20(3). 545–551. 22 indexed citations
15.
Bergesio, Franco, Paolo Conti, G.B. John Mancini, et al.. (2001). Nodular macroglossia with combined light chain and beta-2 microglobulin deposition in a long-term dialysis patient.. PubMed. 14(2). 128–31. 3 indexed citations
16.
Miliani, A, Franco Bergesio, & Maurizio Salvadori. (1996). Familial AL-amyloidosis in three Italian siblings.. Haematologica. 81(2). 105–9. 4 indexed citations
17.
Miliani, A & Franco Bergesio. (1995). AL-amyloidosis in monoclonal gammopathies.. PubMed. 79(4). 364–6. 3 indexed citations
18.
Amato, Maria Pia, F Cozzolino, Franco Bergesio, et al.. (1988). In Vitro Interleukin-1 Production by Different Dialysis Membranes. Nephrology Dialysis Transplantation. 3(4). 432–434. 9 indexed citations
19.
Salvadori, Maurizio, et al.. (1988). Aspects of Biocompatibility of Two Different Dialysis Membranes: Cuprophane and Polysulfone. The International Journal of Artificial Organs. 11(3). 175–180. 13 indexed citations
20.
Bergesio, Franco, et al.. (1988). Renal Involvement in Igd Myeloma. Scandinavian Journal of Urology and Nephrology. 22(4). 309–312. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Rosengren Breakdown of academic impact, for papers by Lisa Mendelson Breakdown of academic impact, for papers by Kai Immonen Breakdown of academic impact, for papers by Sabahat Alışır Breakdown of academic impact, for papers by Yousuf Razvi Breakdown of academic impact, for papers by R. Baatard Breakdown of academic impact, for papers by Mattia Zampieri Breakdown of academic impact, for papers by Lenka Bauerová Breakdown of academic impact, for papers by Feng Ding Breakdown of academic impact, for papers by Alessia Argirò
Rankless by CCL
2026